$BXBL Balance Sheet | Understand Stock

$BXBL

$2.81 -$0.19 (6.33%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024
ASSETS
Current assets
Cash and Cash Equivalents
Prepaid expenses
Deferred offering cost
Total current assets
Cash and investments held in trust account
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
Accounts payable
Accrued offering cost
Tax liability
Promissory note
TOTAL LIABILITIES
Forward purchase agreement liability, at fair value
TOTAL CURRENT LIABILITIES
Common stock; $0.0001 par value, subject to possible redemption, 8,000,000 shares at redemption value
Common stock, shares subject to possible redemption
Total common stock; $0.0001 par value, subject to possible redemption, 8,000,000 shares at redemption value
STOCKHOLDERS’ EQUITY (DEFICIT)
Common stock, $0.0001 par value; 100,000,000 shares authorized; 2,295,800 issued and outstanding (excluding 8,000,000 shares subject to possible redemption)
Common stock, shares not subject to possible redemption
Total common stock, $0.0001 par value; 100,000,000 shares authorized; 2,295,800 issued and outstanding (excluding 8,000,000 shares subject to possible redemption)
Additional paid in capital
Retained earnings (accumulated deficit)
Total Stockholders’ Equity (Deficit)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

Comments